FDA recall record

Photofrin (porfimer sodium) for Injection, 75 mg Single Use Flip-Top Vial recall — FDA D-1157-2014

Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.

Class IIIclassification
D-1157-2014official record ID
Mar 19, 2014report date

Recall record at a glance

Official recordD-1157-2014
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmPinnacle Biologics Inc.
Report dateMar 19, 2014
Recall initiation dateFeb 10, 2014
Quantity261 vials
LocationBannockburn, IL, United States

Official product description

Photofrin (porfimer sodium) for Injection, 75 mg Single Use Flip-Top Vial, Rx Only. Manufactured for: Pinnacle Biologics, Inc. Bannockburn, IL 60015. NDC:76128-155-75

Why the product was recalled

Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.

Distribution information

US: Nationwide and Taiwan

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.